The Prevalence of Alternative-complementary Therapies in Patients with Multiple Sclerosis

Objective: Multiple sclerosis (MS) is a chronic demyelinating/degenerative disease of the central nervous system that causes disability in young adults. Complementary medicine (CM) and alternative medicine (AM) as a concept is outside the scope of traditional medicine and generally includes all diag...

Full description

Bibliographic Details
Main Authors: Rabia Gökçen Gözübatık Çelik, Musa Öztürk, Serap Altın, Mesrure Köseoğlu, Hande Sariahmetoğlu, Mesude Tütüncü, Aysun Soysal
Format: Article
Language:English
Published: Galenos Yayinevi 2019-09-01
Series:Türk Nöroloji Dergisi
Subjects:
Online Access:http://www.tjn.org.tr/jvi.aspx?pdir=tjn&plng=eng&un=TJN-04207&look4=
_version_ 1797919325361799168
author Rabia Gökçen Gözübatık Çelik
Musa Öztürk
Serap Altın
Mesrure Köseoğlu
Hande Sariahmetoğlu
Mesude Tütüncü
Aysun Soysal
author_facet Rabia Gökçen Gözübatık Çelik
Musa Öztürk
Serap Altın
Mesrure Köseoğlu
Hande Sariahmetoğlu
Mesude Tütüncü
Aysun Soysal
author_sort Rabia Gökçen Gözübatık Çelik
collection DOAJ
description Objective: Multiple sclerosis (MS) is a chronic demyelinating/degenerative disease of the central nervous system that causes disability in young adults. Complementary medicine (CM) and alternative medicine (AM) as a concept is outside the scope of traditional medicine and generally includes all diagnostic and treatment methods for which scientific data are insufficient. Facilitating access to alternative-complementary therapies makes their use widespread. The aim of this study was to evaluate the knowledge level of patients with MS by using a questionnaire and the knowledge of the perception of AM. Materials and Methods: Patients who were definitively diagnosed as having MS-clinically isolated syndrome in the clinic of our hospital were included on a voluntary basis. Sociodemographic characteristics, type of MS, date of diagnosis, number of attacks, and MS disability scale were recorded. The questionnaire, which was prepared for alternative or complementary therapies used, was completed by the same researcher. Data were analysed using SPSS 21 program Results: Two hundred ten patients with MS were included in our study. It was determined that all patients were aware of AM/CM treatments, the highest rate of information was obtained from the internet (76%), 1.4% AM, 49% CM was used. Ninety-seven % of the patients received TT for the purpose of relieving their symptoms (p≤0.005). Mostly garlic (83.4%), caper (79.6%), ginger (69.9%), and goat’s milk (60%) was used. CM was statistically significantly higher in the first decade (p≤0.005). It was observed that 32% of the patients used TT after the 2nd MS attack without any significance. Conclusion: Our study showed that patients with MS used CM temporarily and with high rates. In contrast to the literature, the rate of use in the first period of the disease was found to be significantly higher. This condition was interpreted as the fact that at the beginning of the disease it could be made with the hope of fighting MS and fully recovering, but after the understanding of the nature of the disease, the use of AM/CM decreased.
first_indexed 2024-04-10T13:43:57Z
format Article
id doaj.art-d0ca04e77f4548d5aefaecf867ee27d9
institution Directory Open Access Journal
issn 1309-2545
language English
last_indexed 2024-04-10T13:43:57Z
publishDate 2019-09-01
publisher Galenos Yayinevi
record_format Article
series Türk Nöroloji Dergisi
spelling doaj.art-d0ca04e77f4548d5aefaecf867ee27d92023-02-15T16:11:02ZengGalenos YayineviTürk Nöroloji Dergisi1309-25452019-09-0125315315810.4274/tnd.galenos.2019.04207The Prevalence of Alternative-complementary Therapies in Patients with Multiple SclerosisRabia Gökçen Gözübatık Çelik0Musa Öztürk1Serap Altın2Mesrure Köseoğlu3 Hande Sariahmetoğlu4Mesude Tütüncü5Aysun Soysal6Istanbul Bakirkoy Prof. Dr. Mazhar Osman Mental Health and Nerve Diseases Training and Research Hospital, Clinic of Neurology, Istanbul, TurkeyIstanbul Bakirkoy Prof. Dr. Mazhar Osman Mental Health and Nerve Diseases Training and Research Hospital, Clinic of Neurology, Istanbul, TurkeyIstanbul Bakirkoy Prof. Dr. Mazhar Osman Mental Health and Nerve Diseases Training and Research Hospital, Clinic of Neurology, Istanbul, TurkeyIstanbul Bakirkoy Prof. Dr. Mazhar Osman Mental Health and Nerve Diseases Training and Research Hospital, Clinic of Neurology, Istanbul, TurkeyIstanbul Bakirkoy Prof. Dr. Mazhar Osman Mental Health and Nerve Diseases Training and Research Hospital, Clinic of Neurology, Istanbul, TurkeyIstanbul Bakirkoy Prof. Dr. Mazhar Osman Mental Health and Nerve Diseases Training and Research Hospital, Clinic of Neurology, Istanbul, TurkeyIstanbul Bakirkoy Prof. Dr. Mazhar Osman Mental Health and Nerve Diseases Training and Research Hospital, Clinic of Neurology, Istanbul, TurkeyObjective: Multiple sclerosis (MS) is a chronic demyelinating/degenerative disease of the central nervous system that causes disability in young adults. Complementary medicine (CM) and alternative medicine (AM) as a concept is outside the scope of traditional medicine and generally includes all diagnostic and treatment methods for which scientific data are insufficient. Facilitating access to alternative-complementary therapies makes their use widespread. The aim of this study was to evaluate the knowledge level of patients with MS by using a questionnaire and the knowledge of the perception of AM. Materials and Methods: Patients who were definitively diagnosed as having MS-clinically isolated syndrome in the clinic of our hospital were included on a voluntary basis. Sociodemographic characteristics, type of MS, date of diagnosis, number of attacks, and MS disability scale were recorded. The questionnaire, which was prepared for alternative or complementary therapies used, was completed by the same researcher. Data were analysed using SPSS 21 program Results: Two hundred ten patients with MS were included in our study. It was determined that all patients were aware of AM/CM treatments, the highest rate of information was obtained from the internet (76%), 1.4% AM, 49% CM was used. Ninety-seven % of the patients received TT for the purpose of relieving their symptoms (p≤0.005). Mostly garlic (83.4%), caper (79.6%), ginger (69.9%), and goat’s milk (60%) was used. CM was statistically significantly higher in the first decade (p≤0.005). It was observed that 32% of the patients used TT after the 2nd MS attack without any significance. Conclusion: Our study showed that patients with MS used CM temporarily and with high rates. In contrast to the literature, the rate of use in the first period of the disease was found to be significantly higher. This condition was interpreted as the fact that at the beginning of the disease it could be made with the hope of fighting MS and fully recovering, but after the understanding of the nature of the disease, the use of AM/CM decreased.http://www.tjn.org.tr/jvi.aspx?pdir=tjn&plng=eng&un=TJN-04207&look4=Multiple sclerosis treatmentalternative medicinecomplementary medicine
spellingShingle Rabia Gökçen Gözübatık Çelik
Musa Öztürk
Serap Altın
Mesrure Köseoğlu
Hande Sariahmetoğlu
Mesude Tütüncü
Aysun Soysal
The Prevalence of Alternative-complementary Therapies in Patients with Multiple Sclerosis
Türk Nöroloji Dergisi
Multiple sclerosis treatment
alternative medicine
complementary medicine
title The Prevalence of Alternative-complementary Therapies in Patients with Multiple Sclerosis
title_full The Prevalence of Alternative-complementary Therapies in Patients with Multiple Sclerosis
title_fullStr The Prevalence of Alternative-complementary Therapies in Patients with Multiple Sclerosis
title_full_unstemmed The Prevalence of Alternative-complementary Therapies in Patients with Multiple Sclerosis
title_short The Prevalence of Alternative-complementary Therapies in Patients with Multiple Sclerosis
title_sort prevalence of alternative complementary therapies in patients with multiple sclerosis
topic Multiple sclerosis treatment
alternative medicine
complementary medicine
url http://www.tjn.org.tr/jvi.aspx?pdir=tjn&plng=eng&un=TJN-04207&look4=
work_keys_str_mv AT rabiagokcengozubatıkcelik theprevalenceofalternativecomplementarytherapiesinpatientswithmultiplesclerosis
AT musaozturk theprevalenceofalternativecomplementarytherapiesinpatientswithmultiplesclerosis
AT serapaltın theprevalenceofalternativecomplementarytherapiesinpatientswithmultiplesclerosis
AT mesrurekoseoglu theprevalenceofalternativecomplementarytherapiesinpatientswithmultiplesclerosis
AT handesariahmetoglu theprevalenceofalternativecomplementarytherapiesinpatientswithmultiplesclerosis
AT mesudetutuncu theprevalenceofalternativecomplementarytherapiesinpatientswithmultiplesclerosis
AT aysunsoysal theprevalenceofalternativecomplementarytherapiesinpatientswithmultiplesclerosis
AT rabiagokcengozubatıkcelik prevalenceofalternativecomplementarytherapiesinpatientswithmultiplesclerosis
AT musaozturk prevalenceofalternativecomplementarytherapiesinpatientswithmultiplesclerosis
AT serapaltın prevalenceofalternativecomplementarytherapiesinpatientswithmultiplesclerosis
AT mesrurekoseoglu prevalenceofalternativecomplementarytherapiesinpatientswithmultiplesclerosis
AT handesariahmetoglu prevalenceofalternativecomplementarytherapiesinpatientswithmultiplesclerosis
AT mesudetutuncu prevalenceofalternativecomplementarytherapiesinpatientswithmultiplesclerosis
AT aysunsoysal prevalenceofalternativecomplementarytherapiesinpatientswithmultiplesclerosis